Nualtis adds oral-film assets and a pipeline as revenue grows
APLE reported nine-month revenue of $7.5M, up 43% year on year, with a 52% gross margin. The company added oral-film assets and a commercialization pipeline.
- published on Newsmetry
- original source published
the same feed is available to bots and dashboards through the api. connect the api →
what happened
According to TradingView, APLE posted nine-month revenue of $7.5 million, up 43% from a year earlier, with a gross margin of 52%.
Nualtis expanded its portfolio with patented oral-film technology and a pipeline of projects aimed at commercialization. The effort is supported in part by convertible debenture financing.
why it matters
For investors, revenue growth and a solid margin matter, but convertible debenture financing could dilute shareholders over time. The news is of limited significance given the company's size.
tags
instruments
sources
- APLE: Nualtis adds oral-film assets and a commercialization pipeline to a growing platform — TradingView, 13 November 2026 at 21:56 UTC
prepared by the newsmetry newsroom with ai assistance from the sources listed below. not investment advice.
alerts on your topics, the morning digest and the api — in your account.
get stories in real time ↗